Clinical Trial: Comparing The Safety And Efficacy Of DEFENCATH(R) In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Posted On: 2025-02-13

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06822426) titled 'Comparing The Safety And Efficacy Of DEFENCATH(R) In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)' on Jan. 15.

Brief Summary: This is a Phase 3, randomized, double-blind, controlled, adaptive, 2-arm, multicenter study to demonstrate the efficacy and safety of DefenCath in adult participants receiving home Total Parenteral Nutrition (TPN) via Central Venous Catheter (CVC) compared with heparin.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Central Line Associated Blood Stream Infections (CLABSI)

Intervention: D...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Comparing The Safety And Efficacy Of DEFENCATH(R) In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)